endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Startups channel feed

Up­dat­ed: Steve Paul, Daphne Zo­har re­unite for an­oth­er neu­ro start­up af­ter Karuna suc­cess

Last year
People
Financing

Mer­ck signs small ac­qui­si­tion to make AD­Cs safer

Last year
Deals

Con­tineum prices $110M IPO as IPF and neu­ro drugs ad­vance

Last year
Financing

Ex­clu­sive: Backed with $350M, se­cre­tive start­up Met­sera jumps in­to the obe­si­ty race

Last year
Financing

Apogee, Spyre founder launch­es its third biotech and heads straight to Nas­daq

Last year
Financing
Deals

An­ti­body biotech Di­ag­o­nal Ther­a­peu­tics lands $128M to pur­sue rare dis­eases

Last year
Financing

Neu­roster­ix emerges with $63M to fol­low Karuna, Cerev­el

Last year
Financing

Prov­i­dence spin­out Pra­ia Health rais­es $20M

Last year
Health Tech

Con­tineum says it will seek $136M in IPO to back its mid-stage neu­ro drug

Last year
Financing

Of the few pre­clin­i­cal IPOs, Metageno­mi keeps de­tails about IND plans close

Last year
Cell/Gene Tx

Bound­less starts IPO spring with $100M list­ing for can­cer small mol­e­cules

Last year
Financing

Ex­clu­sive: Athena Coun­tou­ri­o­tis' Aven­zo nabs $150M to in-li­cense more as­sets

Last year
Financing

Nu­va­tion inks all-stock deal for US-Chi­na on­col­o­gy biotech An­Heart

Last year
Deals
China

No­vo to buy mid-stage heart fail­ure biotech Car­dior for up to $1.1B

Last year
Deals
Pharma

Bound­less Bio seeks $88M in IPO as it runs two Ph1 can­cer tri­als

Last year
Financing

For­mer Prometheus ex­ecs raise $400M for pre­ci­sion im­munol­o­gy start­up: 'The band is back to­geth­er'

Last year
Financing

Ex­clu­sive: ‘If you could hal­lu­ci­nate a pro­tein’: Proflu­ent snags $35M for gen­er­a­tive AI mod­els

Last year
Financing
AI

The megaround re­bound: Pri­vate biotechs rack up $100M+ fi­nanc­ings

Last year
Financing

Clasp Ther­a­peu­tics emerges with $150M based on work from Bert Vo­gel­stein, Drew Par­doll

Last year
Financing

'Cell ther­a­py with­out cell­s': Cap­stan rais­es $175M to test in vi­vo CAR-T

Last year
Financing
Cell/Gene Tx

Mid-stage neu­ro­science start­up En­grail rais­es $157M

Last year
Financing

Con­tineum Ther­a­peu­tics files for IPO with MS drug in PhII

Last year
Financing

It takes GUTS to be BOLD: A look at the new biotech tick­ers

Last year

Pfiz­er-backed UK biotech rais­es £25M to ad­vance mi­tophagy pipeline

Last year
Financing
First page Previous page 17181920212223 Next page Last page
A service from the Financial Times